Category: Toxicology
A Closer Look at Ocular Toxicity Studies
The eye and the ocular adnexa are common target organs in toxicology studies, but the appropriate evaluation of ocular tissues is a specialized endeavor. Compared to routine toxicity studies, ocular toxicity studies require methodological modifications at almost every stage from study design to the final pathology report. EPL has extensive experience in the processing and […]
The Benefits of Entrusting Your Histopathology Services to EPL
Companies who outsource the histopathology component of their valuable studies need to know that the work will be performed to the highest quality standards, on time, and at competitive prices. Although claims of quality are easily made, true quality can be a difficult metric to gauge. So let’s look at the evidence. Unlike its few […]
EPL Announces New President
EPL is pleased to announce the promotion of Dr. Kathleen Funk to President of EPL on June 1, 2016. Dr. Funk has served as the Chief Operating Officer since 2014. Dr. Funk is a graduate of the Virginia-Maryland Regional College of Veterinary Medicine and also holds a PhD in Comparative Pathology from the University of […]
EPL, Inc. Opens a Northeast Office in Collegeville, Pennsylvania
Experimental Pathology Laboratories, Inc. (EPL®) established EPL Northeast on February 8, 2016. This office is headed by Dr. Heath Thomas who was formerly Vice President of Safety Assessment at GlaxoSmithKline. The Northeast office is located outside of Philadelphia at 125 Chinaberry Lane, Collegeville, PA. With this location, Dr. Thomas will be able to provide local […]
Meet Aclairo Pharmaceutical Development Group
Imagine a group of great scientists and all around nice folks who worked with another group for years in dovetailed projects for their clients. It does not take much imagination to wonder why these folks would want to be in one happy group together. On January 1, 2016, EPL, Inc. acquired Aclairo PDG, Inc. as […]
Experimental Pathology Laboratories, Inc. (EPL) Acquires Aclairo Pharmaceutical Development Group, Inc.
EPL and Aclairo Combine Preclinical Services Expertise EPL is pleased to announce that it has acquired Aclairo Pharmaceutical Development Group, Inc. (Aclairo) which provides independent and objective nonclinical, regulatory, and clinical ADME/DMPK expert strategy and implementation to the pharmaceutical and drug device industries. “Aclairo’s team of industry and ex-FDA experts have developed a specialized consultancy […]
On-Time Pathology Reporting
It is every client’s desire and expectation that their study report will be completed “On-Time” or better yet, be available ahead of schedule. There are a number of factors that determine whether a pathology report will be early, on time, or in the worst case scenario, delayed. Most situations are readily managed, but in rare […]
Drug-induced Vascular Injury (DIVI): An Often Complicated Issue
Drug-induced vascular injury (DIVI) is a major concern for development of new and novel therapies. Efforts to identify biomarkers consistent with DIVI have not been successful, largely attributed to the complex nature of the vascular responses to injury and a lack of understanding of the mechanisms controlling these responses. Recent publications on biomarkers of DIVI […]
EPL Clinical Pathology Evaluation and Consultation Services
Experimental Pathology Laboratories, Inc. (EPL) is pleased to announce that Dr. Valerie Barlow will be providing clinical pathology evaluation and consultation services for EPL. Dr. Valerie G. Barlow holds a DVM, a Master of Science and Ph.D., and is a Diplomate of the American College of Veterinary Pathologists (clinical pathology). Dr. Barlow was born and […]
EPL, Inc. Opens a Midwest Office in West Lafayette, Indiana
Experimental Pathology Laboratories, Inc. (EPL) opened a Midwest facility on September 1, 2014. This office is headed by Dr. Paul Snyder formerly a Professor at Purdue University. The Midwest office is located in the Purdue Research Park at 1305 Cumberland Ave., West Lafayette, IN. With this central location, Dr. Snyder will be able to provide local […]